Welcome to the 7th Microbiome Movement - Drug Development Summit Europe
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases. With more indications being pursued, and more trials being run than ever before, our ability as a community to overcome challenges around safety, delivery and commercialisation will define the next stage of microbiome drugs.
Returning to London in January, the 7th Microbiome Movement- Drug Development Summit Europe will unite Europe’s leading drug developers and microbiome experts to share their latest discoveries on microbiome functionality, translation, clinical development, biomarker discovery and manufacturing scale-up. As we return face-to-face, the 2023 summit will foster collaboration among clinicians, researchers, and industry.
Don’t miss this opportunity to get together in person to form vital partnerships that can turn microbiome science into business!
40+ Expert Speakers Including:
Principal Investigator & Microbiome Group Leader
Isabelle De Cremoux
Chief Executive Officer
Founder & Chief Executive Officer
Chief Executive Officer & Founder
Science Director Europe
Chief Executive Officer & Co-Founder, Director
Bloom Science Inc.
Eric J. C. Gálvez
Research Postdoctoral Fellow, Microbiome
Hear What Our Customers Say
"We need to combine our efforts to accelerate the knowledge and translation into the clinic, and the Microbiome Movement is offering exactly what we are needing."
- Institut Gustave Roussy
"In a field with many conferences of varying quality, the Microbiome Drug Development Summit consistently delivers substantive and compelling conversations and a collaborative vibe"